Tapentadol in Chronic Malignant Tumour Related Pain

NCT01264887 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Administrative reasons

Conditions

Cancer
Chronic Pain
Pain

Interventions

DRUG: Tapentadol Prolonged Release

Sponsor

Grünenthal GmbH